278 related articles for article (PubMed ID: 21385118)
1. Toll-like receptors as potential therapeutic targets in cardiac dysfunction.
Hofmann U; Ertl G; Frantz S
Expert Opin Ther Targets; 2011 Jun; 15(6):753-65. PubMed ID: 21385118
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
Frantz S; Ertl G; Bauersachs J
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction.
Navi A; Patel H; Shaw S; Baker D; Tsui J
Vascul Pharmacol; 2013 Mar; 58(3):231-9. PubMed ID: 23070056
[TBL] [Abstract][Full Text] [Related]
4. Targeting the toll-system in cardiovascular sciences.
Földes G; von Haehling S; Jankowska EA; Anker SD
Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):57-67. PubMed ID: 19075967
[TBL] [Abstract][Full Text] [Related]
5. Roles of toll-like receptors signaling in organ transplantation.
Li T; Chen G; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.
Chao W
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H1-12. PubMed ID: 19011041
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
[TBL] [Abstract][Full Text] [Related]
9. Role of toll-like receptors in cardiovascular diseases.
Vallejo JG
Clin Sci (Lond); 2011 Jul; 121(1):1-10. PubMed ID: 21413930
[TBL] [Abstract][Full Text] [Related]
10. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
[TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
12. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
[TBL] [Abstract][Full Text] [Related]
13. Drugs targeting Toll-like receptors.
Krishnan J; Lee G; Choi S
Arch Pharm Res; 2009 Nov; 32(11):1485-502. PubMed ID: 20091261
[TBL] [Abstract][Full Text] [Related]
14. [Expression and function of toll-like receptors in B lymphocytes].
Liu HZ; Yang HZ; Hu ZW
Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):114-8. PubMed ID: 18664173
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor modulators: a patent review (2006-2010).
Basith S; Manavalan B; Lee G; Kim SG; Choi S
Expert Opin Ther Pat; 2011 Jun; 21(6):927-44. PubMed ID: 21406035
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like receptors (TLRs) and their ligands.
Uematsu S; Akira S
Handb Exp Pharmacol; 2008; (183):1-20. PubMed ID: 18071652
[TBL] [Abstract][Full Text] [Related]
18. [Toll-like receptors and the significance for clinical medicine].
Wiersinga WJ; van der Poll T
Ned Tijdschr Geneeskd; 2005 May; 149(21):1150-5. PubMed ID: 15940918
[TBL] [Abstract][Full Text] [Related]
19. The role of Toll-like receptors in the pathogenesis of renal disease.
Czyzyk J
Semin Nephrol; 2006 Mar; 26(2):167-72. PubMed ID: 16530608
[TBL] [Abstract][Full Text] [Related]
20. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
